SYDNEY, AUSTRALIA - 16th May - 19th July
SYDNEY, May 28, 2026 /PRNewswire/ -- Sistine Chapel: Revelations – An Immersive Exhibition opens for a limited season from May 16 to July 19 at St Mary's Cathedral, offering a rare opportunity to step inside one of the world's greatest artistic achievements. Created in collaboration with the Vatican and the Catholic Archdiocese of Sydney, and brought to life through large-scale projections and cutting-edge immersive technology, this one-of-a-kind experience surrounds visitors with Michelangelo's masterpieces, revealing the stories, symbolism and detail like never before.
Unlike the Sistine Chapel in Rome, where the artwork is viewed from a distance, here one is fully immersed within it. Free to look up, move through the space, and experience the ceiling as a living, unfolding narrative that has inspired centuries of faith, creativity and human imagination.
"Michelangelo's work speaks to something universal in us; our search for meaning, beauty and connection," said Juliette Khoury, Project Lead. "This exhibition opens that conversation up to a whole new audience, in a way that feels alive and deeply human, but also current and immersive."
Running for a strictly limited time, Revelations is set to be one of Sydney's most in-demand cultural events. A world-class experience on par with leading immersive exhibitions globally.
Visitors will journey through Michelangelo's work - from creation to redemption - in a specially constructed, large-scale environment designed exclusively for this exhibition.
With strong demand expected and sessions limited, early booking is recommended.
Book Tickets Now: https://sistinechapelsydney.com.au/#tickets
Don't miss your chance to experience the Sistine Chapel like never before.
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
Tickets Now on Sale For One of the Year's Standout Cultural Events
--New Adhesive Enables Reliable Bonding in Both Light and Shadowed Areas
SINGAPORE, May 28, 2026 /PRNewswire/ -- Dymax, a global manufacturer of light-curing materials and equipment, today announced the release of HLC-M-1004, a low viscosity adhesive designed to support efficient assembly of complex medical devices.
HLC‑M‑1004 expands the HLC™ Adhesives portfolio, which utilizes a hybrid light‑curable platform to support curing in both light‑exposed and shadowed areas. The adhesive combines on‑contact cure in dark areas with rapid, low‑intensity UV or visible‑light curing to support fast, reliable manufacturing.
Designed for medical device assembly, HLC-M-1004 is well-suited for applications involving catheters, diagnostic and therapeutic devices, and other parts that incorporate opaque or light-blocking substrates. The adhesive delivers low viscosity for controlled dispensing and penetration into tight bond gaps, enabling consistent bond formation without the need for primers.
Additional performance benefits include limited blooming with proper light curing, flexibility after cure, and improved aesthetics. The material provides rapid fixturing to support high-throughput manufacturing processes.
HLC-M-1004 has been evaluated in accordance with applicable ISO 10993 biocompatibility standards and contains no nonreactive solvents. As a one-part material, it helps manufacturers simplify processes, reduce waste, and improve overall production efficiency.
With the addition of HLC-M-1004, Dymax continues to expand the HLC Adhesive family to address evolving bonding challenges in medical device assembly environments.
About Dymax
Dymax develops innovative rapid and light-curable materials, dispensing equipment, and UV/LED light-curing systems. The company's adhesives, coatings, and equipment are perfectly matched to work seamlessly with each other, providing design engineers with tools to dramatically improve manufacturing efficiencies. Major markets include aerospace and defense; medical device; and consumer and automotive electronics.
For additional information on Dymax, visit www.dymax.com or call us at +65 6752 2887.
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
Dymax Expands HLC Adhesive Portfolio with New Low Viscosity Medical Product
